Navigation Links
American Society for Microbiology honors Lucas R. Hoffman
Date:9/14/2007

Washington, DC September 13, 2007 One of the 2007 American Society for Microbiology (ASM) ICAAC Young Investigator Awards sponsored by Merck and Company, Inc., U.S. Human Health, will be presented to Lucas R. Hoffman, M.D., Ph.D., Acting Assistant Professor in Pediatrics, Division of Pulmonary Pediatrics, Childrens Hospital and Regional Medical Center, Seattle, Washington. Dr. Hoffman is being honored for his research excellence in microbiology and infectious disease.

Dr. Hoffman has distinguished himself in his field through his significant research findings. These have been published in several journals, including twice in the prestigious Proceedings of the National Academies of Science.

He is well known for his approach to complex problems, which he can successfully reduce to their essence and examine with an orderly method. His significant accomplishments have led to his receiving several awards from the Cystic Fibrosis Foundation, among others. He is particularly known for a paper published in Nature in 2005 describing how aminoglycoside antibiotics induce biofilm formation, which could have a very profound impact on the care of patients with cystic fibrosis. A subsequent paper published in the Proceedings of the National Academy of Sciences in 2006 demonstrated the novel interaction between P. aeruginosa and Staphylococcus aureus in the presence of antibiotics. His ongoing research on P. aeruginosa is supported by an NIH Mentored Clinical Scientist Development Award.

Dr. Hoffman received his B.S. degree in Chemistry from the University of California, Berkeley, where he was valedictorian, and his M.D. and Ph.D. from the University of California, San Francisco. He completed his postgraduate residency and fellowship at the Childrens Hospital and Regional Medical Center, Seattle, Washington.


'/>"/>

Contact: Peggy McNult
pmcnult@asmusa.org
202-942-9225
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/7/2020)... NEW YORK (PRWEB) , ... April 07, 2020 , ... ... at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. In addition, PTW announces ... and Drug Administration and is now available for sale within the United States. The ...
(Date:4/1/2020)... ... March 30, 2020 , ... eMazzanti Technologies, an award-winning ... that the previously announced Align2020 conference will be conducted virtually. , Align2020 ... executives as they face current cyber security, compliance and collaboration challenges. , The ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... it has named Jean-François Duliere as a European Regulatory Advisor. Effective 1 April ... regulatory compliance and facilities design for biotechnology, oral solid dosage (OSD), and sterile ...
Breaking Biology News(10 mins):
(Date:3/3/2020)... ... March 03, 2020 , ... ... to present the latest breast implant technology at the IMCAS Innovation Shark Tank ... innovations in the dermatology, plastic surgery, and aesthetic science industries that promise to ...
(Date:2/21/2020)... ... ... In a free session on Tuesday, March 10, 2020 at 11am ... MS, Vice President Rare, Orphan and Pediatric Diseases, and Rachael Young, Associate Director, Feasibility ... sites and sponsors. , When planning a rare disease clinical trial, drug developers can ...
(Date:2/21/2020)... ... 2020 , ... Pharmaceutical manufacturers are under increasing pressure to ... new approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing and intense ... But with an industry with the world’s tightest regulations and complex value chains, ...
(Date:2/13/2020)... DUBLIN (PRWEB) , ... February 12, 2020 , ... ... affairs, and pharmacovigilance (PV) solutions and services, is adopting Veeva Vault Safety™ ... databases are a requirement for fast assessment of data, processing of safety information ...
Breaking Biology Technology: